EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments

Go back to EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments
(NASDAQ: EYPT) Delayed: 4.58 +0.01 (0.22%)
Previous Close $4.57    52 Week High
Open $4.53    52 Week Low
Day High $4.69    P/E N/A 
Day Low $4.49    EPS
Volume 1,901,890